Cargando…

Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone

The mineralocorticoid receptor (MR) is a ligand dependent transcription factor. MR has been traditionally associated with the control of water and electrolyte homeostasis in order to keep blood pressure through aldosterone activation. However, there is growing evidence indicating that MR expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz-Durango, N., Vecchiola, A., Gonzalez-Gomez, L. M., Simon, F., Riedel, C. A., Fardella, C. E., Kalergis, A. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581510/ https://www.ncbi.nlm.nih.gov/pubmed/26448944 http://dx.doi.org/10.1155/2015/652738

Ejemplares similares

Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension
por: Muñoz-Durango, Natalia, et al.
Publicado: (2016)

Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess
por: Tapia-Castillo, Alejandra, et al.
Publicado: (2021)

Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division
por: Vecchiola, Andrea, et al.
Publicado: (2020)

The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone
por: Bamberg, Krister, et al.
Publicado: (2019)

Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology
por: Funder, John W.
Publicado: (2017)

Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
por: Dinh, Quynh N, et al.
Publicado: (2012)

Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
por: Gorini, Stefania, et al.
Publicado: (2019)

A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8(+) T Cells in a Nonalcoholic Steatohepatitis Mouse Model
por: Muñoz-Durango, Natalia, et al.
Publicado: (2020)

Interaction of the Mineralocorticoid Receptor With RACK1 and Its Role in Aldosterone Signaling
por: Kuppusamy, Maniselvan, et al.
Publicado: (2017)

Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology
por: Cannavo, Alessandro, et al.
Publicado: (2018)

The Glucocorticoid Receptor is Required for Efficient Aldosterone-Induced Transcription by the Mineralocorticoid Receptor.
por: Johnson, Thomas A., et al.
Publicado: (2023)

The Kidneys and Aldosterone/Mineralocorticoid Receptor System in Salt-Sensitive Hypertension
por: Shibata, Shigeru, et al.
Publicado: (2011)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2021)

Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists
por: Yoshida, Yuichi, et al.
Publicado: (2021)

SAT-LB012 Differential miRNA-Transcriptomic and Proteomic Profile in Urinary Exosomes of Subjects with "Nonclassic" Apparent Mineralocorticoid Excess Syndrome
por: Tapia, Alejandra, et al.
Publicado: (2019)

FRI164 The Glucocorticoid Receptor is Required for Efficient Aldosterone-induced Transcription by the Mineralocorticoid Receptor
por: Johnson, Thomas A, et al.
Publicado: (2023)

SAT-055 The Aldosterone-Renin Ratio Predicts Cardiometabolic Disorders in Subjects without Classic Primary Aldosteronism
por: Vecchiola, Andrea
Publicado: (2019)

Downregulation of exosomal miR-192-5p and miR-204-5p in subjects with nonclassic apparent mineralocorticoid excess
por: Tapia-Castillo, Alejandra, et al.
Publicado: (2019)

SAT-564 Effectiveness of Treatment with Mineralocorticoid Receptor Antagonistsin Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2020)

SAT-561 Effects of Mineralocorticoid Receptor Antagonists on Primary Aldosteronism Screening
por: Tezuka, Yuta, et al.
Publicado: (2020)

Cardiac Hypertrophy and Fibrosis in the Metabolic Syndrome: A Role for Aldosterone and the Mineralocorticoid Receptor
por: Essick, Eric E., et al.
Publicado: (2011)

The Diuretic Torasemide Does Not Prevent Aldosterone-Mediated Mineralocorticoid Receptor Activation in Cardiomyocytes
por: Gravez, Basile, et al.
Publicado: (2013)

Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease
por: Gorini, Stefania, et al.
Publicado: (2018)

PSUN68 Finerenone for Primary Aldosteronism: A Novel Mineralocorticoid Receptor Antagonist
por: Aurora, John, et al.
Publicado: (2022)

Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review
por: Mai, Xurong, et al.
Publicado: (2022)

Beneficial Effects of Proanthocyanidins in the Cardiac Alterations Induced by Aldosterone in Rat Heart through Mineralocorticoid Receptor Blockade
por: Martín-Fernández, Beatriz, et al.
Publicado: (2014)

Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis
por: Harvey, Adam P., et al.
Publicado: (2017)

The Aldosterone-Mineralocorticoid Receptor Pathway Exerts Anti-Inflammatory Effects in Endotoxin-Induced Uveitis
por: Bousquet, Elodie, et al.
Publicado: (2012)

Aldosterone Inhibits In Vitro Myogenesis by Increasing Intracellular Oxidative Stress via Mineralocorticoid Receptor
por: Lee, Jin Young, et al.
Publicado: (2021)

A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift
por: Epstein, Murray
Publicado: (2022)

Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro
por: Vecchiola, Andrea, et al.
Publicado: (2013)

A Relationship between the aldosterone - mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans
por: Aoun, E.G., et al.
Publicado: (2017)

G Protein-Coupled Estrogen Receptor 1 (GPER1) Mediates Aldosterone-Induced Endothelial Inflammation in a Mineralocorticoid Receptor-Independent Manner
por: Tang, Ziwei, et al.
Publicado: (2021)

Unravelling drug-induced hypertension: molecular mechanisms of aldosterone-independent mineralocorticoid receptor activation by posaconazole
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2018)

Mineralocorticoid Receptor-Dependent Impairment of Baroreflex Contributes to Hypertension in a Mouse Model of Primary Aldosteronism
por: Shi, Luo, et al.
Publicado: (2019)

Renin-Angiotensin-Aldosterone System Inhibition and Mineralocorticoid Receptor Antagonists: The Overriding Importance of Enablers and Dampers
por: Epstein, Murray
Publicado: (2021)

Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism
por: Lin, Yu-Fang, et al.
Publicado: (2020)

Aldosterone Suppresses Endothelial Mitochondria through Mineralocorticoid Receptor/Mitochondrial Reactive Oxygen Species Pathway
por: Peng, Shih-Yuan, et al.
Publicado: (2022)

Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury
por: Nakamura, Toshifumi, et al.
Publicado: (2022)

Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis
por: Moss, Mary E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_clt6fk8kq9v1lvkabr88jkholm